Pediatric News - Cipro
Thursday, January 1st, 2009 (ciprofloxacin, Bayer Pharmaceuticals)
The Food and Drug Administration approved ciprofloxacin for patients aged 1-17 years to treat complicated urinary tract infections and pyelonephritis caused by Escherichia coli (not as first-line therapy).
* Recommended Dosage: For complicated urinary tract infections (UTIs) or pyelonephritis, the i…
